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Abstract
The oxidation of codeine on glassy carbon electrodes has been studied in detail using differential pulse voltammetry.
The results obtained using a glassy carbon electrode clearly show a much more complex oxidation mechanism than
that previously reported when platinum and gold electrodes were used. To clarify the codeine oxidative profile,
several metabolites and analogues of this alkaloid, codeine N-oxide, norcodeine, dihydrocodeine, acetylcodeine and 6-
chlorodesoxycodeine, were synthesized and studied. It was deduced that the anodic waves observed in codeine
oxidation are related to the presence of methoxy, hydroxy and tertiary amine groups. Due to the similarity of
potentials at which these oxidative processes take place, at some pHs an overlap of peaks occurs and only one anodic
wave is observed.
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1. Introduction
Codeine is an alkaloid from the opiate drug class that has
important effects on the central nervous system including
analgesic and mood-altering effects [1]. For medical pur-
poses, it is usually used either alone or in combination to
treat mild to moderate pain and as cough suppressant,
because it has good antitussive properties. Narcotic effects
of codeine, although less potent, resemble those of mor-
phine and hence addiction can occur. This ability constitutes
one of the main limitations of its clinical use. In fact, about
40 percent of people who use it meet the criteria for codeine
dependence [2] and the use of codeine-containing products
is strongly associated with endogenous depression, again a
dual-diagnosis problem [3].
The increment of drugmisuse over the past decades led to
an increase of codeine and dihydrocodeine, the 7,8-dihydro
analogue of codeine (Fig. 1), in drug prescriptions as
substitutes and alternative drugs for the management of
heroin in some European countries [4, 5]. However, the
presence of these drugs as a contributory factor in deaths
from narcotic overdoses has also been reported [5, 6].
The determination of codeine and dihydrocodeine in
biological samples is a common practice in many laborato-
ries involved in forensic and clinical toxicology. In addition,
it is also important for pharmacological studies to determine
codeine and its metabolites in biological samples. Therefore
the development of sensitive, rapid and simple method-
ologies for its analysis are welcome.
Although some electrochemical methods are described in
the literature for determination of codeine in pharmaceutical
and biological samples [7 ±9] little is known about its
oxidative profile. Moreover, until the middle 80×s codeine
was stated to be devoid of electroactivity [10]. The voltam-
metric study of codeine and dihydrocodeine at platinum and
gold electrodes revealed a single anodic wave related to the
oxidationof the 6-hydroxy group (Fig. 1) fromwhich resulted
the formation of a quinonoid type structure [11]. Never-
theless, other studies involving the use of glassy carbonandof
modifiedelectrodes showed theappearanceofmore thanone
anodic wave that were not identified [12, 13].
In order to clarify the oxidation process occurring for
codeine and to identify all anodic waves observed, the
synthesis of several codeine metabolites and derivatives




Voltammetric measurements were performed using an
Autolab PGSTAT 10 potentiostat/galvanostat (EcoChimie,
Netherlands) and a one-compartment glass 663 VA Met-
rohm cell with a three-electrode configuration (Metrohm).
The electrodes used were a glassy carbon working electrode
with a diameter of 2 mm (Metrohm), a glassy carbon rod
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counter electrode (Metrohm) and an Ag/AgCl (3 M KCl)
reference electrode (Metrohm). The working electrode was
polished with alumina (BDH) on a microcloth pad and
rinsed with water before use.
A Metrohm E-520 pH-meter and a Metrohm glass
electrode were used for pH measurements. Melting points
were obtained on a Kˆfler microscope (Reichert Thermo-
var). Infrared spectra were recorded on a ATI Mattson
Genesis Series FTIR spectrophotometer using potassium
bromide disks (Uvasol, Merck). 1H and 13C NMR (1H
decoupled) data were acquired, at room temperature, on a
Br¸ker AMX 300 spectrometer operating at 300.13 and
75.47 MHz, respectively. Chemical shifts are expressed as 
(ppm) values relative to tetramethylsilane (TMS) as inter-
nal reference; CDCl3 was used as sample solvent. Assign-
ments were also made from DEPT (distortionless enhance-
ment by polarization transfer) (underline values). Electron
impact mass spectra (EI-MS) were obtained out on a VG
AutoSpec instrument and data are reported as m/z (% of
relative intensity of the most important fragments).
2.2. Other Conditions
Thin-layer chromatography (TLC) was performed on pre-
coated silica gel 60 F254 plates (E. Merck). The layer
thickness was 0.2 and 0.1 mm, respectively. The following
chromatographic systemswere used: chloroform/methanol/
diethylamine (8 :1.5 :0.5), carbon tetrachloride/butanol/
methanol/ammonia (4 :3 : 3 :0.3), chloroform/acetic acid/
diethylamine (8 :1.5 :0.5).The spots were visualized under
UV detection (254 and 366 nm) and iodine vapor. Purifica-
tion of the compounds was performed by column chroma-
tography using Merck silica gel 60 (0.2 ± 0.5 mm, E. Merck)
or aluminium oxide, activated basic, Brockmann I (ca.
150 mesh, 58 ä, Aldrich). Solvents were evaporated in a
B¸chi Rotavapor.
2.3. Reagents and Solutions
Codeine hydrochloride was obtained fromUquipa (Lisbon,
Portugal) and was used without further purification. Norco-
deine hydrochloride was kindly donated by the United
Nations Drug Control Programme (Vienna, Austria).
Dihydrocodeine bitartrate was a gift from Asta Medica
(Lisbon, Portugal). Reagents used in the synthetic proce-
dures were obtained from Sigma-Aldrich Quimica (Sintra,
Portugal). All other reagents and solvents were pro analysis
grade and purchased from Merck (Lisbon, Portugal). m-
Chloroperbenzoic acid (free of m-chlorobenzoic acid) was
purified according the procedure of Bortolini et al. [14].
Deionized water with conductivity less than 0.1 S cm1 was
used throughout. Buffer solutions employed were 0.2 M in
the pH range 1.2 ± 12.2 [15].
2.3.1. Synthesis of Codeine N-Oxide (Codeine Oxide)
The preparation of codeine N-oxide was adapted from the
procedure proposed by Craig and Purushothaman [16].
Codeine hydrochloride (1.0 g) was dissolved in 25 mL of
water containing a trace of sodium metabisulfite at 10 C.
One equivalent of concentrated aqueous ammonia was
added dropwise, with stirring. The coolingwas continued for
an additional 15 min. and during this time a white solid
appeared in the solution. The crystals of codeine free base
were filtered and washed with ice-cold water.
A solution ofm-chloroperbenzoic acid (0.15 g) in 5 mL of
chloroformwas added gradually, at 0 ± 5 C, to an ice-cooled
solution of codeine free base (0.23 g) in 5 mLof chloroform.
Stirring was continued for 4 hours, during which themixture
was allowed to come to room temperature. After solvent
evaporation the residue was purified by column chromatog-
raphy (alkaline alumina; chloroform chloroform/metha-
nol 9 : 1). The fractions containing the major product were
collected, the solvent evaporated, and the residue recrystal-
lized from ethanol. The crystals were washed with diethyl
ether and dried in a oven.
The analytical data of the compoundwere similar to those
found in the literature [17 ± 23].
Fig. 1. Structural formulae of a) codeine, b) norcodeine, c)
codeine N-oxide, d) dihydrocodeine e) acetylcodeine, and f) 6-
chlorodesoxycodeine.
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2.3.2. Synthesis of Acetylcodeine (6-O-Acetylcodeine; 3-O-
Methyl-6-O-acetylmorphine)
Codeine hydrochloride (0.5 g) was dissolved in a mixture of
25 mL of dry pyridine and 30 mL of acetic anhydride and
maintained at room temperature for 24 h. After complete
reaction the solution was poured into a beaker containing
ice. The crude product was extracted with chloroform (3
20 mL). The combined organic phaseswerewashedwith 5%
hydrochloric acid and water and dried over anhydrous
sodium sulfate. After evaporation of the solvent, a residue
was obtained and recrystallized with diethyl ether. Acetyl-
codeine was obtained as white crystals. The analytical data
of the compound was similar to that found in the literature
[24].
2.3.3. Synthesis of 6-Chlorodesoxycodeine (6-Chloro-4,5-
epoxy-3-methoxy-N-methyl-7,8-didehydromorphin-
an)
This codeine congener was prepared using a modified
version of a reported procedure [25]. A solution of p-
toluenesulfonyl chloride (0.34 g) in pyridine (2 mL) was
added dropwise to an ice-cooled solution of codeine (0.5 g)
in 3 mL of pyridine. The reaction mixture was allowed to
stand at 5 C for 4 h and then poured into ice-water with
rapid stirring. The medium was alkalinized with concen-
trated aqueous ammonia and themixturewas extractedwith
chloroform (3 50 mL). The combined organic extracts
were washed with water and dried over anhydrous sodium
sulfate. The melting point of the tosylate was similar to that
referred in the literature [25].
The tosylate was dissolved in a mixture of ether and
hexamethylphosphoramide and dry lithium chloride (0.2 g)
was added to the solution. The reaction mixture was stirred
overnight at room temperature. After the usual workup a
white solid was obtained (80% yield) [26 ± 28].
M.p. 156 ± 158 C. 13C NMR: 119.2 (CH, C1), 112.8
(CH, C2), 141.8 (C3), 145.6 (C4), 98.8 (CH, C5), 53.8
(CH, C6), 135.2 (CH, C7), 128.6 (CH, C8), 58.6 (CH, C9),
20.2 (CH2, C10), 127.4 (C11), 130.0 (C12), 44.4 (C13), 39.9
(CH, C14), 36.2 (CH2, C15), 46.6 (CH2, C16), 56.2 (OCH3),
43.1 (NCH3).EI-MS: 319 ([M 2] ., 44), 317 ([M] ., 63), 282
(100).
3. Results and Discussion
Codeine is fairly stable in the solid state, but in aqueous
solutions degrades relatively rapidly in the presence of
strong acids and bases [29]. In this degradation process,
isomerization reactions play an important role [20]. More-
over, some factors, such as pH, temperature and counter-ion
or buffering species could also contribute to the degradation
of codeine [29].
Some specific congeners possessing important function-
alities that could help to understand the oxidative profile of
codeine were synthesized: codeine N-oxide, acetylcodeine
and 6-chlorodesoxycodeine, as described in the experimen-
tal section.
3.1. Electrochemical Oxidation
In order to understand codeine×s oxidative pathways and to
assess the influence of pH on its degradation, a detailed
voltammetric study was carried out.
The electrochemical behavior of codeinewas studied over
the pH interval 1.2 to 12.2, at a glassy carbon working
electrode using differential pulse voltammetry (Figs. 2 and
3a). It was seen that the anodic oxidation of codeine follow a
very complex mechanism that is pH dependent.
The anodic wave observed starting at pH 2,Ep1.19 V,
appears to be the result of the sum of two close peaks. These
peaks might be related with the oxidation of the tertiary
amine and the 6-hydroxy groups (Scheme 1), based on two
observations. First, at pH 3 the peak at Ep1.15 V,
Fig. 2. a) 3D plot and b) plots of Ep (filled symbols) and Ip (open
symbols) vs. pH from differential pulse voltammograms of 100 M
codeine in different buffer electrolytes as function of pH. Scan
rate 5 mV s1.
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presents a well-defined shoulder after the main peak
(Fig. 2), meaning that the two peaks are almost super-
imposed. The second observation is the behavior of codeine
derivatives at this pH.
By studying the electrochemical behavior of norcodeine,
codeineN-oxide and 6-chlorodesoxycodeine (Figs. 1, 3b, 3c
and 3f) it is possible to draw some conclusions. Norcodeine
presents an anodicwave at pH 2atEp1.17 V, that can be
attributed to the 6-hydroxy group, given the absence of the
tertiary amine group (Fig. 4). 6-Chlorodesoxycodeine also
presents an anodic wave, Ep1.21 V, at this pH. Since in
the 6-position there is a chloride instead of a hydroxy group
the peak should correspond to the oxidation of the tertiary
amine group (Fig. 4). Since codeine molecules have both
these two groups, it is not surprising that a single wave
appears at Ep1.19 V corresponding to their oxidation.
At pH 4 it is possible to observe two well-defined anodic
peaks for codeine, Ep1.07 Vand 1.20 V (Figs. 2 and
3). Thesewaves should result fromoxidation of the tertiary
amine and 6-hydroxy groups (Scheme 1) which are now
separated. In fact, the decrease of peak potential with
increasing pH observed for the oxidation of the tertiary
amine group together with the pH independent potential
corresponding to oxidation of the hydroxy group until
pH 5 means there is a separation between the two peaks
(Fig. 3).
The identification of these two anodic waves, involving
the tertiary amine and 6-hydroxy group, was confirmed by
considering and comparing the voltammetric behavior of
codeine and norcodeine at pH 4 the first peak observed for
codeine is absent for norcodeine (Fig. 5). Theonly structural
difference between codeine and norcodeine is in the amine
Fig. 3. Plots of Ep vs. pH from differential pulse voltammograms of 100 M solutions of a) codeine, b) norcodeine, c) codeine N-oxide,
d) dihydrocodeine, e) acetylcodeine and f) 6-chlorodesoxycodeine in different buffer electrolytes. Scan rate 5 mV s1. (–) Slope
59.2 mV/pH unit.
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group, codeine has a tertiary and norcodeine a secondary
amine group (Fig. 1). Thus this peak could only be related
with the oxidation of the tertiary amine group. The
oxidation of the tertiary amine group leads to the formation
of a secondary amine group (i.e., norcodeine) and an
aldehyde [30]. The assignment of the second peak to
oxidation of the 6-hydroxy group could be made by
examining the data obtained for the other compounds
studied and, particularly, considering the behavior of
norcodeine (Fig. 3b). As seen, the peak position is pH
independent until pH 5 and above pH 9. This result is
undoubtedly important for peak identificationmade since it
is in agreementwith the pKa values of 5.7 and 9.1 given in the
literature for norcodeine [24, 31]. The results obtained for
dihydrocodeine (Fig. 3d) are particularly significant in
supporting this assignment. In fact, the nonexistence of the
double bond in the neighborhood of the 6-hydroxy group of
dihydrocodeine (Fig. 1) makes its oxidation practically
impossible at these potentials.
The experimental evidence presented above and the data
available in the literature [11] lead to assignment of the
second peak to the oxidation of the 6-hydroxy group. In
order to try and confirm this, further studies involvingmodel
compounds, dextromethorphan and 3-methoxymorphinan,
were carried out by differential pulse voltammetry. These
compounds are structurally related with codeine although
they do not possess the 6-hydroxy function. In the literature,
the occurrence of a new oxidative metabolite arising from
oxidation of the benzylic carbon (C-10) present in the
codeine and morphine structures is referred to [32 ± 34].
Nevertheless, the results obtained were not sufficiently
elucidative in order to prove or disprove the hypothesis of
the oxidation of the benzylic carbon in codeine (data not
shown).
At pH 8 it is possible to observe three anodic peaks for
codeine (Figs. 2 and 3a). The appearance of a newwave atEp
1.21 V can be attributed to the oxidation of the 3-
methoxy group. In support of this assignment, the peak
Scheme 1.
Fig. 4. Differential pulse voltammograms in pH 2 KCl/HCl
supporting electrolyte of 100 M solutions: (- - - -) norcodeine
and ( ¥¥ ¥ ¥ ¥ ) 6-chlorodesoxycodeine. Scan rate 5 mV s1.
Fig. 5. Differential pulse voltammograms in pH 4 acetate buffer
of 100 M solutions: (–) codeine and (- - - -) norcodeine. Scan
rate 5 mV s1.
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potential does not depend on the solution pH, the peak
potential is the same as that for more simple compounds
with this group, such as anisole and p-methylanisole (data
not shown), and the peak appears in all compounds studied
(all have this substituent).
At pH 9 and 10 four anodic waves are observed (Figs. 2
and 6).A small shoulder is seen near the second peak, which
means that probably the second peak is, for lower pHs, also
the result of the sum of two anodic waves. This new peak, is
probably related with a subsequent oxidative process
involving the secondary amine group from the oxidation
of the tertiary amine group present in codeine. The similar
behavior of codeine and norcodeine at these pHs (Fig. 6)
and the results obtained for the closely related compound
norheroin where a secondary amine group is the only
oxidizable group present (data not shown) reinforces this
assignment. Moreover, this explains clearly the similarity in
oxidative behavior of codeine and 6-chlorodesoxycodeine
or acetylcodeine, compounds in which the 6-hydroxy group
is not present (Fig. 6). If the second peak appearing for
codeine at Ep1.20 V (pH 4) were merely a result of
oxidation of the 6-hydroxy group, see Figure 5, it should not
be present for acetylcodeine or 6-chlorodesoxycodeine.
More experimental evidence is obtained from the results for
codeine and acetylcodeine at pH 9 (Fig. 6). As seen, contra-
rily to that observed for codeine, acetylcodeine presents
only one anodic peak at this pH at a potential similar to that
of the shoulder.
4. Conclusions
The oxidation behavior of codeine and dihydrocodeine was
studied over a large pH interval. It was verified that in
aqueous solution codeine and dihydrocodeine oxidation
mechanisms are coincident, follow a very complex pH-
dependent mechanism. To understand and clarify its oxida-
tive mechanism, a series of metabolites and analogues of
codeine were synthesized and their voltammetric behavior
studied. From analysis of the data obtained for all the
compounds it was concluded that the oxidative profile of
codeine is a consequence of the oxidation of methoxy,
hydroxy and tertiary amine groups present in the molecule.
Moreover, it was found that further oxidation of the product
deriving from the tertiary amine group occurs at the
electrode surface. These results will contribute to a better
understanding of the oxidative behavior of codeine and to
the development of new analytical methodologies, based on
electrochemical detection, for its monitoring.
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